Now that E*TRADE has joined forces with Morgan Stanley, get actionable insights from our combined companies.
Artificial intelligence
Accelerating innovations in artificial intelligence and robotics are powering a new surge in automation, thanks primarily to cheaper and increasingly powerful computing capabilities. The biotech sector, for example, has been using machine learning and AI to discover new drugs more quickly and efficiently. AI and automation could have a similarly transformative impact on other industries, and companies will need to embrace these technologies to thrive.
The funds below invest in companies that do business in areas related to robotics, machine learning, artificial intelligence, and related technologies.
ETFs
Data as of ET
Fund Name / Symbol
Overall Morningstar
Rating
Rating
Category
Market Price
Today's %
Change
Change
Expense
Ratio
Ratio
Data quoted represents past performance. Past performance is not an indication of future results and investment returns and share prices will fluctuate on a daily basis. Your investment may be worth more or less than your original cost when you redeem your shares. Current performance may be lower or higher than the performance data quoted. For most recent month-end performance and current performance metrics, please click on the fund name.
*Morgan Stanley Research, The Deflation Enablers, July 20, 2022.
Get insights from Morgan Stanley
What investors need to know about breakthroughs in AI, healthcare, and brain implants
The development of human-machine interfaces is taking a leap forward. Learn what it means for investors.
Why some investors are tapping into the $6 trillion opportunity in AI
Artificial intelligence (AI) may offer game-changing innovations in technology for consumers.
Megatrends: Powering a new automation age
Aging populations and lower technology costs are propelling companies to invest more in productivity-boosting automation. What could this mean for investors?
Why artificial intelligence could spur a paradigm shift for biotech
Biotechs are applying AI and machine learning to drug development, potentially creating dozens of new medicines and a $50 billion market over the next decade. Here’s what it means for patients and investors.
Check out other thematic investing topics
Technology pacesetters
Learn how to invest in leading technology innovators that are looking to change the way the world works.
Gamers
Look for opportunities in one of the biggest sectors of the entertainment industry: video gaming.
Cybersecurity
Consider investing in companies that help safeguard data and computer systems.
Health care innovators
Discover how to put your money behind health care and biotechnology companies that are pursuing medical breakthroughs.
Start investing today
Enjoy $0 commissions on online US-listed stock, ETF, mutual fund, and options trades with no account minimums.1